Cytiva has launched its BioChallenge competition in Southeast Asia to empower small to medium sized biotech companies in the fields of cell engineering, process development, as well as isolation and purification. Winners of the BioChallenge will be awarded up to SG$200 000 in FastTrak services so that they can scale up efficiently, mitigate risks, and reduce time to go to market.

Since its introduction in 2018, Cytiva's BioChallenge has supported research, bioprocessing development and commercialization of over 130 projects globally in the form of $4 million worth of products and services.

In addition to BioChallenge, Cytiva supports the biotech community in Southeast Asia through the Cytiva Experience Learning Lab (CELL), which was established in Singapore in 2021. CELL has to date conducted more than 70 training sessions with tertiary academic and research institutes on the latest bioprocessing and production techniques for the development of advanced therapeutics.

Firman Ghouze, Marketing Director, Asia Pacific at Cytiva says "By launching the BioChallenge in Southeast Asia, we hope to foster a culture of cooperation and open innovation with governments, think tanks and institutions to address these challenges and empower promising biotech startups with the speed and flexibility to bring highly advanced innovations from molecule to market."